Last week I wrote about Iran, the only country in the world that pays kidney donors.
Iran shows that a kidney market need not resemble organ trafficking. Indeed, its market is closely regulated and has pre-empted the exploitative and abusive illegal markets found in many other countries.
Iran’s program has flaws, such as lack of follow-up for donors and limited support for poor recipients, that are typical of an underdeveloped health system. But the program also has lessons for countries like the United States, where the wait for a kidney can be as long as a decade.